Post-discharge healthcare utilization in infants with neonatal opioid withdrawal syndrome

Shikhar Shrestha1, Melissa H Roberts2, Jessie R Maxwell3

  • 1Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA (Current Affiliation), United States of America; Department of Pharmacy Practice and Administrative Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM (Institution where the research was carried out), United States of America.

Insights

Infants with neonatal opioid withdrawal syndrome (NOWS) experience increased healthcare use after discharge, particularly those with severe cases. This highlights the need for enhanced post-discharge care for these vulnerable infants.

Area of Science:

  • Neonatal Health
  • Public Health
  • Healthcare Utilization

Background:

  • The opioid epidemic has increased neonatal opioid withdrawal syndrome (NOWS) incidence.
  • Long-term consequences and healthcare needs of NOWS infants are not well understood.

Purpose of the Study:

  • To evaluate post-discharge healthcare utilization in infants with NOWS.
  • To examine the association between NOWS severity and healthcare utilization.

Main Methods:

  • Retrospective cohort study using the CERNER Health Facts® database.
  • Identified NOWS and uncomplicated births using ICD-9/ICD-10 codes.
  • Analyzed rehospitalization, ED visits, and composite utilization within one year post-discharge.

Main Results:

  • NOWS infants showed higher composite one-year healthcare utilization, especially severe cases.
  • Full-term infants with NOWS had increased odds of 30-day and one-year rehospitalization.
  • Severity indicators included pharmacologic treatment and hospitalization length.

Conclusions:

  • Infants diagnosed with NOWS exhibit elevated healthcare utilization in their first year.
  • Severe NOWS is linked to greater post-discharge healthcare needs.
  • Closer post-discharge follow-up and management are crucial for NOWS infants.

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
637
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
87
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
76
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
566
Discharge Summary Forms01:31

Discharge Summary Forms

The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
1.1K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
994